Fulgent Genetics Inc. (FLGT) Insider Trading

Last 12 months

Insiders sold $678k and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. The last open-market buy by an executive or director was in Mar 2025.

Net open-market

−$678k

0 buys · 15 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 2

executives and directors

Last open-market buy

Mar 2025

Mar 5, 2025

Get an email when FLGT's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 2	Jian Xie President and COO	SoldNo plan	2,127	$19.66	$42k	0.4%	Form 4
Sep 2	Hanlin Gao Chief Scientific Officer	SoldNo plan	1,673	$19.66	$33k	0.2%	Form 4
Aug 27	Jian Xie President and COO	SoldNo plan	1,193	$19.91	$24k	0.2%	Form 4
Aug 27	Hanlin Gao Chief Scientific Officer	SoldNo plan	939	$19.91	$19k	<0.1%	Form 4
Jun 2	Jian Xie President and COO	SoldNo plan	2,146	$17.89	$38k	0.4%	Form 4
Jun 2	Hanlin Gao Chief Scientific Officer	SoldNo plan	1,688	$17.89	$30k	0.2%	Form 4
May 27	Jian Xie President and COO	SoldNo plan	1,201	$17.60	$21k	0.2%	Form 4
May 27	Hanlin Gao Chief Scientific Officer	SoldNo plan	945	$17.60	$17k	<0.1%	Form 4
Dec 2, 2025	Jian Xie President and COO	SoldNo plan	1,140	$28.33	$32k	0.2%	Form 4
Dec 2, 2025	Hanlin Gao Chief Scientific Officer	SoldNo plan	1,075	$28.33	$30k	0.1%	Form 4
Nov 28, 2025	Jian Xie President and COO	SoldNo plan	1,198	$29.57	$35k	0.2%	Form 4
Nov 28, 2025	Hanlin Gao Chief Scientific Officer	SoldNo plan	943	$29.57	$28k	<0.1%	Form 4
Nov 24, 2025	Jian Xie President and COO	SoldNo plan	681	$30.47	$21k	0.1%	Form 4
Nov 24, 2025	Hanlin Gao Chief Scientific Officer	SoldNo plan	535	$30.47	$16k	<0.1%	Form 4
Nov 19, 2025	Jian Xie President and COO	SoldNo plan	10,000	$29.10	$291k	1.8%	Form 4
Sep 3, 2025	Jian Xie President and COO	SoldNo plan	1,128	$22.03	$25k	0.2%	Form 4
Sep 3, 2025	Hanlin Gao Chief Scientific Officer	SoldNo plan	1,063	$22.03	$23k	0.1%	Form 4
Aug 27, 2025	Jian Xie President and COO	SoldNo plan	1,199	$21.48	$26k	0.2%	Form 4
Aug 27, 2025	Hanlin Gao Chief Scientific Officer	SoldNo plan	943	$21.48	$20k	<0.1%	Form 4
Aug 25, 2025	Jian Xie President and COO	SoldNo plan	696	$21.50	$15k	0.1%	Form 4
Aug 25, 2025	Hanlin Gao Chief Scientific Officer	SoldNo plan	548	$21.50	$12k	<0.1%	Form 4
Jun 2, 2025	Hanlin Gao Chief Scientific Officer	SoldNo plan	754	$20.29	$15k	<0.1%	Form 4
Jun 2, 2025	Jian Xie President and COO	SoldNo plan	1,135	$20.29	$23k	0.2%	Form 4
May 27, 2025	Jian Xie President and COO	SoldNo plan 2 parts	1,873	$20.54 average	$38k	0.3%	Form 4
May 27, 2025	Hanlin Gao Chief Scientific Officer	SoldNo plan 2 parts	1,039	$20.54 average	$21k	0.1%	Form 4
Mar 5, 2025	Paul Kim CFO and Treasurer	Bought	100,000	$15.96	$1.6M	40%	Form 4
Dec 3, 2024	Jian Xie President and COO	SoldNo plan	1,455	$19.50	$28k	0.3%	Form 4
Dec 3, 2024	Hanlin Gao Chief Scientific Officer	SoldNo plan	1,373	$19.50	$27k	0.1%	Form 4
Nov 25, 2024	Hanlin Gao Chief Scientific Officer	SoldNo plan	497	$18.26	$9k	<0.1%	Form 4
Nov 25, 2024	Ming Hsieh Chief Executive Officer	SoldNo plan	2,227	$18.26	$41k	<0.1%	Form 4
Nov 25, 2024	Jian Xie President and COO	SoldNo plan	689	$18.26	$13k	0.1%	Form 4

Sep 2No plan
Jian Xie
President and COO · sold 2,127 at $19.66
$42k
0.4% of stake
Sep 2No plan
Hanlin Gao
Chief Scientific Officer · sold 1,673 at $19.66
$33k
0.2% of stake
Aug 27No plan
Jian Xie
President and COO · sold 1,193 at $19.91
$24k
0.2% of stake
Aug 27No plan
Hanlin Gao
Chief Scientific Officer · sold 939 at $19.91
$19k
<0.1% of stake
Jun 2No plan
Jian Xie
President and COO · sold 2,146 at $17.89
$38k
0.4% of stake
Jun 2No plan
Hanlin Gao
Chief Scientific Officer · sold 1,688 at $17.89
$30k
0.2% of stake
May 27No plan
Jian Xie
President and COO · sold 1,201 at $17.60
$21k
0.2% of stake
May 27No plan
Hanlin Gao
Chief Scientific Officer · sold 945 at $17.60
$17k
<0.1% of stake
Dec 2, 2025No plan
Jian Xie
President and COO · sold 1,140 at $28.33
$32k
0.2% of stake
Dec 2, 2025No plan
Hanlin Gao
Chief Scientific Officer · sold 1,075 at $28.33
$30k
0.1% of stake
Nov 28, 2025No plan
Jian Xie
President and COO · sold 1,198 at $29.57
$35k
0.2% of stake
Nov 28, 2025No plan
Hanlin Gao
Chief Scientific Officer · sold 943 at $29.57
$28k
<0.1% of stake
Nov 24, 2025No plan
Jian Xie
President and COO · sold 681 at $30.47
$21k
0.1% of stake
Nov 24, 2025No plan
Hanlin Gao
Chief Scientific Officer · sold 535 at $30.47
$16k
<0.1% of stake
Nov 19, 2025No plan
Jian Xie
President and COO · sold 10,000 at $29.10
$291k
1.8% of stake
Sep 3, 2025No plan
Jian Xie
President and COO · sold 1,128 at $22.03
$25k
0.2% of stake
Sep 3, 2025No plan
Hanlin Gao
Chief Scientific Officer · sold 1,063 at $22.03
$23k
0.1% of stake
Aug 27, 2025No plan
Jian Xie
President and COO · sold 1,199 at $21.48
$26k
0.2% of stake
Aug 27, 2025No plan
Hanlin Gao
Chief Scientific Officer · sold 943 at $21.48
$20k
<0.1% of stake
Aug 25, 2025No plan
Jian Xie
President and COO · sold 696 at $21.50
$15k
0.1% of stake
Aug 25, 2025No plan
Hanlin Gao
Chief Scientific Officer · sold 548 at $21.50
$12k
<0.1% of stake
Jun 2, 2025No plan
Hanlin Gao
Chief Scientific Officer · sold 754 at $20.29
$15k
<0.1% of stake
Jun 2, 2025No plan
Jian Xie
President and COO · sold 1,135 at $20.29
$23k
0.2% of stake
May 27, 2025No plan
Jian Xie
President and COO · sold 1,873 at avg $20.54
$38k
0.3% of stake
May 27, 2025No plan
Hanlin Gao
Chief Scientific Officer · sold 1,039 at avg $20.54
$21k
0.1% of stake
Mar 5, 2025
Paul Kim
CFO and Treasurer · bought 100,000 at $15.96
$1.6M
40% of stake
Dec 3, 2024No plan
Jian Xie
President and COO · sold 1,455 at $19.50
$28k
0.3% of stake
Dec 3, 2024No plan
Hanlin Gao
Chief Scientific Officer · sold 1,373 at $19.50
$27k
0.1% of stake
Nov 25, 2024No plan
Hanlin Gao
Chief Scientific Officer · sold 497 at $18.26
$9k
<0.1% of stake
Nov 25, 2024No plan
Ming Hsieh
Chief Executive Officer · sold 2,227 at $18.26
$41k
<0.1% of stake
Nov 25, 2024No plan
Jian Xie
President and COO · sold 689 at $18.26
$13k
0.1% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch FLGT, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Medical Laboratories

CSTLCastle Biosciences, Inc.

BLLNBillionToOne, Inc.

BNRBurning Rock Biotech Ltd

XGNExagen Inc.

Spot a number that looks wrong? Check it in FLGT's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing FLGT

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.